This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Norman E. Sharpless, M.D. (Acting), Commissioner of Food and Drugs

Event Date: 10/21/2019
Location: Bethesda, MD
Subject: National Institutes of Health Tobacco Regulatory Science Meeting: FDA New Regulatory Policy for Tobacco
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, academia, industry and other invited guests

Event Date: 10/21/2019
Location: Rockville, MD
Subject: FDA Public Meeting on New Era of Smarter Food Safety
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, media, industry and other registered guests

Event Date: 10/22/2019
Location: Washington, DC
Subject: National Organization for Rare Disorders (NORD) Rare Disease & Orphan Products Breakthrough Summit
FDA Participant/Group: PETER MARKS; JEFFREY SHUREN; CARLYLE MCWILLIAMS; JANET MAYNARD; LUCAS KEMPF; JANET WOODCOCK;
Non FDA Participant/Group: Government, industry, academia, media and other invited guests

Event Date: 10/23/2019
Location: Washington, DC
Subject: Capitol Hill Briefing to Celebrate the 25th Anniversary of the Food and Drug Administration Office of Women's Health
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Government, congressional staff, public and other invited guests

Event Date: 10/24/2019
Location: Washington, DC
Subject: Foundation for National Institutes of Health (FNIH) Board of Directors Meeting: FDA Update
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, members of the FNIH Board and other invited guests

Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner

Event Date: 10/21/2019
Location: Washington, DC
Subject: National Academy of Medicine (NAM) 49th Annual Meeting: Shaping Next Generation Delivery Using Artificial Intelligence
FDA Participant/Group: N/A
Non FDA Participant/Group: Participants from various sectors including industry and academia.

Event Date: 10/22/2019
Location: Silver Spring, MD
Subject: MDEpiNet Annual Meeting
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Participants from various sectors including industry, government, and academia.

Event Date: 10/25/2019
Location: Dallas, TX
Subject: Texas-Israel Healthcare Alliance Innovation Conference
FDA Participant/Group: N/A
Non FDA Participant/Group: Participants from various sectors including industry and academia.

Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs

No Significant Event

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response

Event Date: 10/22/2019
Location: Silver Spring, MD
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: DONALD PRATER; LARRY MORRIS; JULIE MOSS; CAITLIN BOON;
Non FDA Participant/Group: Julie Pierce (Food Standards Agency, United Kingdom);

Event Date: 10/24/2019
Location: College Park, MD
Subject: Safe Food Coalition Meeting
FDA Participant/Group: Several FDA officials and staff members
Non FDA Participant/Group: Group of consumer, public health, whistle-blower, and labor organizations

Event Date: 10/25/2019
Location: Silver Spring, MD
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: LARRY MORRIS; DONALD PRATER; CAITLIN BOON;
Non FDA Participant/Group: Hilary Thesmar, Stephanie Harris (Food Marketing Institute);

Official Name: Lowell Schiller, Principal Associate Commissioner for Policy

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name: Laura Caliguiri, Associate Commissioner for External Affairs

No Significant Event

Official Name: RADM Denise Hinton, Chief Scientist

No Significant Event

Official Name: Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

Event Date: 10/22/2019
Location: Washington, DC
Subject: National Organization for Rare Disorders (NORD) Summit - Town Hall: A Conversation with FDA Center Directors
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, industry, academia, media, and other invited guests

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 10/20/2019
Location: San Antonio, TX
Subject: AABB (Formerly known as American Association of Blood Banks): Advancing Safety of the Blood Supply and Supporting Development of Transfusion Medicine and Cellular Therapies
FDA Participant/Group: Several FDA representatives
Non FDA Participant/Group: Stakeholders in the fields of transfusion medicine and cellular therapies

Event Date: 10/22/2019
Location: Philadelphia, PA
Subject: International Society for Cell and Gene Therapy / American Society for Transplantation and Cellular Therapy Training Course: Regulatory Case Studies and Career Opportunities
FDA Participant/Group: N/A
Non FDA Participant/Group: Several representatives from International Society for Cell and Gene Therapy / American Society for Transplantation and Cellular Therapy

Event Date: 10/23/2019
Location: New York, NY
Subject: Big Pharma: Fireside Chat on Cell and Gene Therapy Development
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, academia, industry, and other invited guests

Event Date: 10/24/2019
Location: New York, NY
Subject: Galien Forum: Delivering on the Patient Promise of Gene Therapy Panel
FDA Participant/Group: N/A
Non FDA Participant/Group: Government, academia, industry, and other invited guests

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Susan T. Mayne, Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Steven Solomon, Director, Center for Veterinary Medicine

Event Date: 10/22/2019
Location: Beltsville, MD
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: United States Department of Agriculture representatives

Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Stacy Cline Amin, Chief Counsel

Event Date: 10/23/2019
Location: Washington, DC
Subject: National Organization for Rare Disorders (NORD) Corporate Council Meeting: Overview of FDA Legal and Policy Issues
FDA Participant/Group: LOWELL SCHILLER; WILLIAM DUNN;
Non FDA Participant/Group: National Organization for Rare Disorders (NORD) members, key staff from congressional committees, Vertex Pharmaceuticals, and Sanofi Genzyme